Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

JOHNSON & JOHNSON JNJ

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, and vision fields. These products are distributed to wholesalers, hospitals, and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.


NYSE:JNJ - Post by User

Bullboard Posts
Post by GoldBug666on Sep 21, 2017 3:46pm
135 Views
Post# 26727583

Status of the Puerto Rico Plants??

Status of the Puerto Rico Plants??
If all of Puerto Rico is without power and there is extensive damage throughout - Remicade won't be produced which is their big Pharma runner also Nucynta and Prezista.  Much doubt that they can switch to another plant that quickly.  There is only an approx 2 week supply at disti centres.  Depending on when the plants come back online and the extent of the damage - this could be a major issue.  Quarter end coming up.  This may be a good candidate to short due to a potential earnings miss.   Also Pfizer is suing due to their Biosimilar being allegedly blocked by JNJ's exclusionary style contracts they (Pfizer) claim. 
Bullboard Posts